The generics cost about USD 500 per month.
The price for Presendin will be determined by whoever owns it after approval, but it's estimated by IXC to be about USD 1,500 per month.
So yes, your triple price ratio for ibuprofen comparison is valid.
Questions to ask Tom in relation to recent announcement dated 27.09.2021, page-70
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.411M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 29320 | 7.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.2¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.12pm 27/08/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable